Literature DB >> 27436815

Genetic epidemiology of melanoma.

Simone Ribero1, Dan Glass2, Veronique Bataille3.   

Abstract

The field of melanoma genetics is moving at great pace with new platforms to investigate single nucleotide polymorphism, genome sequencing, gene expression, and methylation. Melanoma incidence is still rising mainly because of screening campaigns, which has increased the number of reported melanomas. However, mortality due to melanoma is not decreasing. Many cutaneous phenotypic risk factors have been linked to melanoma, but the association with UV radiation is very complex. The level of vitamin D affects both the risk of melanoma and prognosis, but more studies are needed. The genetics of melanoma involves genes involved in pigmentation and naevi, as well as genes involved in the cell cycle and senescence, which have been identified via genome-wide association studies over the last 10 years. One area of research highly relevant to melanoma is telomere biology with further links to reduced senescence. At the somatic level, new gene pathways are being explored with many new therapeutic targets, and boosting immune responses against the tumour appears to offer the best long-term outcome.

Entities:  

Keywords:  genetics; melanoma; risk; screening; sun; vitamin D

Mesh:

Substances:

Year:  2016        PMID: 27436815     DOI: 10.1684/ejd.2016.2787

Source DB:  PubMed          Journal:  Eur J Dermatol        ISSN: 1167-1122            Impact factor:   3.328


  13 in total

Review 1.  cAMP-mediated regulation of melanocyte genomic instability: A melanoma-preventive strategy.

Authors:  Nathaniel C Holcomb; Robert-Marlo Bautista; Stuart G Jarrett; Katharine M Carter; Madeline Krentz Gober; John A D'Orazio
Journal:  Adv Protein Chem Struct Biol       Date:  2018-12-05       Impact factor: 3.507

2.  LncRNA MALAT1 Promotes the Proliferation, Migration, and Invasion of Melanoma Cells by Downregulating miR-23a.

Authors:  Pan Wang; Liu Hu; Guili Fu; Jingjing Lu; Yuanquan Zheng; Ying Li; Lin Jia
Journal:  Cancer Manag Res       Date:  2020-07-29       Impact factor: 3.989

Review 3.  Research Progress of Cell Lineage Tracing and Single-Cell Sequencing Technology in Malignant Skin Tumors.

Authors:  Ang Li; Baoyi Liu; Jingkai Xu; Yong Cui
Journal:  Front Surg       Date:  2022-06-16

4.  α-MSH-PE38KDEL Kills Melanoma Cells via Modulating Erk1/2/MITF/TYR Signaling in an MC1R-Dependent Manner.

Authors:  Xilin Liu; Hong Li; Xianling Cong; Da Huo; Lele Cong; Guangzhi Wu
Journal:  Onco Targets Ther       Date:  2020-12-03       Impact factor: 4.147

5.  LncRNA HOXA11-AS regulates the proliferation and epithelial to mesenchymal transition of human skin cancer cells.

Authors:  Jigang Wang; Xiuli Li; Hui Li; Xin Li
Journal:  3 Biotech       Date:  2021-01-02       Impact factor: 2.406

6.  Identification of 15 lncRNAs Signature for Predicting Survival Benefit of Advanced Melanoma Patients Treated with Anti-PD-1 Monotherapy.

Authors:  Jian-Guo Zhou; Bo Liang; Jian-Guo Liu; Su-Han Jin; Si-Si He; Benjamin Frey; Ning Gu; Rainer Fietkau; Markus Hecht; Hu Ma; Udo S Gaipl
Journal:  Cells       Date:  2021-04-22       Impact factor: 6.600

7.  Association between VDR Gene Polymorphisms and Melanoma Susceptibility in a Colombian Population.

Authors:  Andres Felipe Aristizabal-Pachon; Yeimy Gonzalez-Giraldo; Angela Yazmin Garcia; Dalia Xiomara Suarez; Angela Rodriguez; Janneth Gonzalez-Santos
Journal:  Asian Pac J Cancer Prev       Date:  2022-01-01

8.  Neferine induces p38 MAPK/JNK1/2 activation to modulate melanoma proliferation, apoptosis, and oxidative stress.

Authors:  Jun Xie; Ming-Hui Chen; Chuan-Peng Ying; Ming-Yi Chen
Journal:  Ann Transl Med       Date:  2020-12

9.  Decreased Expression of CPEB3 Predicts a Poor Prognosis in Patients with Melanoma: A Study Based on TCGA Data.

Authors:  Xiaomin Zhang; Yanhua Liang
Journal:  Biomed Res Int       Date:  2021-01-11       Impact factor: 3.411

10.  Development of an Immune-Related Gene Signature for Prognosis in Melanoma.

Authors:  Jia-An Zhang; Xu-Yue Zhou; Dan Huang; Chao Luan; Heng Gu; Mei Ju; Kun Chen
Journal:  Front Oncol       Date:  2021-01-21       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.